Icosavax (ICVX)
US Market

Icosavax (ICVX) Stock Price & Analysis


ICVX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.28 - $16.45
Previous Close$10.04
Average Volume (3M)154.52K
Market Cap
Enterprise Value$325.55M
Total Cash (Recent Filing)$197.65M
Total Debt (Recent Filing)$8.80M
Price to Earnings (P/E)-4.3
Sep 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.31
Shares Outstanding41,426,850
10 Day Avg. Volume188,159
30 Day Avg. Volume154,516
Standard Deviation0.41
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit559.36
Enterprise Value/Ebitda-3.28
Price Target Upside147.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Icosavax’s price range in the past 12 months?
Icosavax lowest stock price was $2.28 and its highest was $16.45 in the past 12 months.
    What is Icosavax’s market cap?
    Currently, no data Available
    When is Icosavax’s upcoming earnings report date?
    Icosavax’s upcoming earnings report date is Sep 11, 2023 which is in 102 days.
      How were Icosavax’s earnings last quarter?
      Icosavax released its earnings results on May 10, 2023. The company reported -$0.6 earnings per share for the quarter, beating the consensus estimate of -$0.614 by $0.014.
        Is Icosavax overvalued?
        According to Wall Street analysts Icosavax’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Icosavax pay dividends?
          Icosavax does not currently pay dividends.
          What is Icosavax’s EPS estimate?
          Icosavax’s EPS estimate is -$0.61.
            How many shares outstanding does Icosavax have?
            Icosavax has 49,796,604 shares outstanding.
              What happened to Icosavax’s price movement after its last earnings report?
              Icosavax reported an EPS of -$0.6 in its last earnings report, beating expectations of -$0.614. Following the earnings report the stock price went up 8.366%.
                Which hedge fund is a major shareholder of Icosavax?
                Among the largest hedge funds holding Icosavax’s share is RA Capital Management. It holds Icosavax’s shares valued at 35M.


                  Icosavax Stock Smart Score

                  The Icosavax stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Icosavax Inc is a biopharmaceutical company. It is committed towards developing safe and effective vaccines against infectious diseases that address important unmet medical needs to save lives and improve health.


                  Top 5 ETFs holding ICVX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Fidelity Growth Opportunities ETF
                  Dimensional US Core Equity Market ETF
                  Vanguard Russell 3000 ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold ICVX. The ETFs are listed according to market value of ICVX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Inovio Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis